CP, ceruloplasmin, 1356

N. diseases: 283; N. variants: 64
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0015695
Disease: Fatty Liver
Fatty Liver
0.010 Biomarker disease BEFREE Multivariate analysis showed that CP, age, high density lipoprotein (HDL) and hemoglobin were independent predictors of HS, and CP, body mass index and HDL were independent predictors of moderate and severe HS. 31076363 2020
CUI: C0151718
Disease: Hypocholesterolemia
Hypocholesterolemia
0.010 Biomarker disease BEFREE Compared with the control group, dietary copper supplementation significantly decreased serum cholesterol (P < 0.05) and significantly increased serum IL-6, ceruloplasmin, SOD, GSH-Px, and liver copper (P < 0.05). 31119639 2020
CUI: C0162739
Disease: HELLP Syndrome
HELLP Syndrome
0.010 AlteredExpression disease BEFREE In addition, there was a positive correlation between the serum Cu and CP levels and the systolic and diastolic blood pressure values and aspartate amino transferase levels (AST), and a negative correlation between the serum Cu and CP levels and the platelet count.<b>Conclusion:</b> This was the first study in which the ceruloplasmin and Cu levels were investigated in HELLP syndrome patients. 29886772 2020
CUI: C0860016
Disease: Fulminant Wilson's disease
Fulminant Wilson's disease
0.010 Biomarker disease BEFREE Our study demonstrated that biochemical markers offer almost as reliable, fast and accurate diagnosis of FWD as offered by ceruloplasmin and 24-hour urinary copper. 31568639 2020
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.010 Biomarker disease BEFREE Delivery of si-LINC00176, oe-LINC00176, si-BCL3 and si-CP plasmids was conducted to explore the effects of LINC00176 on ovarian cancer. 31668012 2020
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.010 Biomarker disease BEFREE Multivariate analysis showed that CP, age, high density lipoprotein (HDL) and hemoglobin were independent predictors of HS, and CP, body mass index and HDL were independent predictors of moderate and severe HS. 31076363 2020
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial
0.010 Biomarker disease BEFREE Delivery of si-LINC00176, oe-LINC00176, si-BCL3 and si-CP plasmids was conducted to explore the effects of LINC00176 on ovarian cancer. 31668012 2020
CUI: C0004936
Disease: Mental disorders
Mental disorders
0.010 Biomarker group BEFREE Neurotrophin levels and oxidative stress markers such as ceruloplasmin and free thiols have been shown to contribute to pathophysiology in several psychiatric disorders. 31779002 2019
CUI: C0007134
Disease: Renal Cell Carcinoma
Renal Cell Carcinoma
0.010 AlteredExpression disease BEFREE Importantly, CP expression correlates with sensitivity to PAX8 silencing and identifies a subset of RCC cases with poor survival. 31431624 2019
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.010 AlteredExpression disease BEFREE Previously we found that kidney tissue and urinary exosomes from patients of diabetic kidney disease showed high levels of ceruloplasmin (CP). 30955187 2019
CUI: C0017665
Disease: Membranous glomerulonephritis
Membranous glomerulonephritis
0.010 AlteredExpression disease BEFREE To investigate this hypothesis, we first measured urine exosomal and kidney expression of CP in non-diabetic chronic kidney disease (CKD) patients (membranous nephropathy, focal segmental glomerulosclerosis, lupus nephritis and IgA nephropathy) followed by a longitudinal study in rat passive Heymann nephritis (PHN), a model of human membranous nephropathy. 30955187 2019
CUI: C0017668
Disease: Focal glomerulosclerosis
Focal glomerulosclerosis
0.010 AlteredExpression disease BEFREE To investigate this hypothesis, we first measured urine exosomal and kidney expression of CP in non-diabetic chronic kidney disease (CKD) patients (membranous nephropathy, focal segmental glomerulosclerosis, lupus nephritis and IgA nephropathy) followed by a longitudinal study in rat passive Heymann nephritis (PHN), a model of human membranous nephropathy. 30955187 2019
CUI: C0018500
Disease: Hair Diseases
Hair Diseases
0.010 AlteredExpression group BEFREE These results enhance our understanding of the function of HEPHL1 and implicate altered ferroxidase activity in hair growth and hair disorders. 31125343 2019
CUI: C0020433
Disease: Hyperbilirubinemia
Hyperbilirubinemia
0.010 AlteredExpression disease BEFREE The severity of his presentation and the disproportionately mild elevation in alkaline phosphatase relative to his hyperbilirubinaemia prompted repeating a ceruloplasmin level, which, though previously normal, was now low, and eventually led to a diagnosis of Wilson disease (WD) with concomitant alcoholic liver disease. 31653639 2019
CUI: C0175754
Disease: Agenesis of corpus callosum
Agenesis of corpus callosum
0.010 Biomarker disease BEFREE Among them, reduced expression levels of ferroportin1 (FPN1) and ceruloplasmin (CP) were significantly correlated with poor survival of ACC patients. 31442954 2019
CUI: C0206686
Disease: Adrenocortical carcinoma
Adrenocortical carcinoma
0.010 AlteredExpression disease BEFREE Reduced expression of ferroportin1 and ceruloplasmin predicts poor prognosis in adrenocortical carcinoma. 31442954 2019
CUI: C0233514
Disease: Abnormal behavior
Abnormal behavior
0.010 Biomarker phenotype BEFREE Neurotrophin levels and oxidative stress markers such as ceruloplasmin and free thiols have been shown to contribute to pathophysiology in several psychiatric disorders. 31779002 2019
Conventional (Clear Cell) Renal Cell Carcinoma
0.010 AlteredExpression disease BEFREE Importantly, CP expression correlates with sensitivity to PAX8 silencing and identifies a subset of RCC cases with poor survival. 31431624 2019
CUI: C0282160
Disease: Aplasia Cutis Congenita
Aplasia Cutis Congenita
0.010 Biomarker disease BEFREE Among them, reduced expression levels of ferroportin1 (FPN1) and ceruloplasmin (CP) were significantly correlated with poor survival of ACC patients. 31442954 2019
CUI: C1260873
Disease: Aortic valve disorder
Aortic valve disorder
0.010 Biomarker disease BEFREE Increased expression of H-ferritin accompanied by elevation of TNF-α (tumor necrosis factor-α) and IL-1β (interleukin-1β) levels, inducers of H-ferritin, corroborates the essential role of ferritin/ferroxidase via attenuating inflammation in calcific aortic valve disease. 30700131 2019
CUI: C1561643
Disease: Chronic Kidney Diseases
Chronic Kidney Diseases
0.010 Biomarker group BEFREE Urine exosomal CP levels were 10-20 times higher in CKD patients than in controls; consistent with this we found high immune-reactive CP localized in tubules and collecting ducts of biopsies of CKD patients. 30955187 2019
CUI: C1861172
Disease: Venous Thromboembolism
Venous Thromboembolism
0.010 Biomarker phenotype BEFREE We assessed associations between CP and venous thromboembolism (VTE) risk in 9933 individuals. 30803124 2019
CUI: C0002170
Disease: Alopecia
Alopecia
0.010 AlteredExpression disease BEFREE Investigation of oxidative stress in patients with alopecia areata by measuring the levels of malondialdehyde and ceruloplasmin in the blood. 30618523 2018
CUI: C0002171
Disease: Alopecia Areata
Alopecia Areata
0.010 AlteredExpression disease BEFREE Investigation of oxidative stress in patients with alopecia areata by measuring the levels of malondialdehyde and ceruloplasmin in the blood. 30618523 2018
CUI: C0007785
Disease: Cerebral Infarction
Cerebral Infarction
0.010 Biomarker disease BEFREE Ceruloplasmin Plays a Neuroprotective Role in Cerebral Ischemia. 30670944 2018